Chemistry:MDMAT

From HandWiki

MDMAT (6,7-methylenedioxy-N-methyl-2-aminotetralin) is a selective serotonin releasing agent (SSRA) and entactogen drug. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA.[1][2] It has been theorized to have less long-term neurotoxicity and less hallucinogenic effects than other MDxx derivatives,[3] but no formal scientific research has been conducted specifically on MDMAT.

There is a lack of research on MDMAT in general, with much of the research and citation in literature being in reference to the wider pharmalogical/chemical class as a whole.

Chemistry

MDMAT is a substituted methylenedioxyphenethylamine, having structural similarities to MDMA and MDA.

See also

References

  1. "Potential psychotropic compounds. VIII. Synthesis and pharmacological activity of 2-aminotetralins related to psychomimetics". Chimica Therapeutica 6 (3): 196. 1971. 
  2. "1,2,3,4-Tetrahydroisoquinoline and related analogs of the phenylalkylamine designer drug MDMA.". Medicinal Chemistry Research 6 (6): 412–26m. January 1996. 
  3. "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry 33 (2): 703–710. February 1990. doi:10.1021/jm00164a037. PMID 1967651.